Health

Acadia Healthcare, one of the largest chains of psychiatric hospitals in the United States, has seen its revenues and stock price skyrocket in recent years. But a New York Times investigation reveals a disturbing truth: Part of that success comes from the exploitation of vulnerable patients. Retaining patients for profit, not to cure them The investigation found evidence that Acadia pressured patients to stay in their facilities, even when they were not medically necessary, to maximize insurance payouts. This practice violates involuntary detention laws, which are designed to protect those who pose a threat to themselves or others. Examples of…

Health researchers often scrutinize various medical treatments to determine their effectiveness, especially for older adults. One noteworthy study, published in the Annals of Internal Medicine, examined the impact of dialysis on older patients with kidney failure, revealing mixed results. The study focused on more than 20,000 veterans, with an average age of 78, and used a simulated trial to explore survival outcomes. The results indicated that starting dialysis immediately after diagnosis only marginally extended life expectancy by about 77 days over three years compared to those who never received dialysis. Georgia Outlaw, a 77-year-old retiree from Williamston, North Carolina, chose…

A serious listeria outbreak has prompted an emergency recall of approximately seven million pounds of deli meats produced by Boar's Head. Initiated in late July, the recall follows numerous reports of serious illnesses and deaths associated with consumption of these products. Source of the epidemic Investigations traced the source of the contamination to a Boar's Head facility in Jarratt, Virginia. Detailed inspections of this site revealed several sanitation issues, including black mold, water leaks in food preparation areas, and insect infestations. These conditions raised significant concerns about overall food safety practices at the plant, which was temporarily closed to address…

Recent research has highlighted a potentially game-changing secondary benefit of Wegovy, an established obesity management drug. In a large clinical trial, individuals taking Wegovy were observed to have a significantly reduced death rate from Covid-19 compared to those not taking the drug. Clinical Trial Insights The study participants, who were already using Wegovy for obesity, contracted Covid-19 at the usual rate expected in the general population. However, their risk of succumbing to the virus was reduced by a third. This remarkable reduction in mortality was surprising and suggests an indirect benefit of the drug that had not previously been recognized.…